Isolation and characterization of a multipotent clone of human embryonal carcinoma cells
References (51)
Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro
Dev Biol
(1984)- et al.
Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells
Differentiation
(1982) - et al.
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis
Cell
(1978) - et al.
Cut, paste and save: new approaches to altering specific genes in mice
Cell
(1989) - et al.
Negative regulation of viral enhancers in undifferentiated embryonic stem cells
Cell
(1985) - et al.
Production of monoclonal antibodies to fibronectin, type IV collagen and other antigens of the human glomerulus
Pathology
(1984) - et al.
Analysis of cell-differentiation lineage in human teratomas using new monclonal antibodies to cytostructural antigens of embryonal carcinoma cells
Differentiation
(1988) - et al.
Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule
Cell
(1981) - et al.
Embryonal carcinoma cell growth and differentiation
Exp Cell Res
(1983) - et al.
Characterization of human embryonal carcinoma cell lines derived from testicular germ-cell tumours
Differentiation
(1985)
Monoclonal antibody to murine embryos defines a stage specific embryonic antigen expressed in mouse embryos and human teratocarcinoma cells
Cell
(1982)
Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells
Dev Biol
(1987)
Dominance and independent segregation of metabolic cooperation-competence and pluripotency in an embryonal carcinoma cell hybrid
Exp Cell Res
(1989)
Developmental characteristics of somatic cell hybrids between totipotent mouse teratocarcinoma and rat intestinal villus cells
Exp Cell Res
(1984)
Intermediate filaments in Merkel cell tumours
Hum Path
(1985)
Human laminin isolated in a nearly intact biologically active form from placenta by limited proteolysis
J Biol Chem
(1983)
Differentially regulated production of platelet-derived growth factor and of transforming growth factor beta by a human teratocarcinoma cell line
Differentiation
(1988)
Immunochemistry of human teratocarcinoma stem cells
Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2
Lab Invest
(1984)
Insulin-like growth factors and the multiplication of Tera-2, a human teratoma-derived cell line
J Cell Sci
(1988)
Vitronectin production by human yolk sac carcinoma cells resembling parietal endoderm
Development
(1988)
The complement of desmosomal plaque proteins in different cell types
J Cell Biol
(1985)
The pathology of human teratomas
Monoclonal antibodies to desmin, the muscle-specific intermediate filament protein
EMBO J
(1983)
Monoclonal antibodies specific for glial fibrillary acidic protein and for each of the neurofilament triplet polypeptides
Differentiation
(1983)
Cited by (100)
How induced pluripotent stem cells changed the research status of polycystic ovary syndrome
2022, Current Progress in iPSC Disease ModelingNeoplasms of the Testis
2020, Urologic Surgical PathologyThe MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays
2018, Stem Cell ReportsCitation Excerpt :NS can represent all cell lineages present during early embryogenesis, including somatic as well as extra-somatic tissues such as YS tumor and choriocarcinoma. They all originate from EC cells, the malignant counterpart of embryonic stem cells (ESCs) (Andrews et al., 1980, 1984; Pera et al., 1989). EC cells, such as ESCs, are characterized by expression of OCT3/4 and SOX2 (de Jong et al., 2008; Looijenga et al., 2003), two transcription factors also used to generate induced pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006).
Stem Cell Biology
2017, Fetal and Neonatal Physiology, 2-Volume SetGrowth Factors and the Serum-Free Culture of Human Pluripotent Stem Cells
2013, Handbook of Stem CellsGrowth Factors and the Serum-Free Culture of Human Pluripotent Stem Cells
2012, Handbook of Stem Cells, Second Edition: Volume 1-2
Copyright © 1989 International Society of Differentiation. Published by Elsevier Inc. All rights reserved.